ESC 365 - Risk of sudden cardiac death after myocardial infarction under contemporary heart failure treatment

Open Access

Risk of sudden cardiac death after myocardial infarction under contemporary heart failure treatment

Session: The role of the primary prevention defibrillator after myocardial infarction in the era of modern heart failure therapy: the PROFID project

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Professor M. Taborsky (Usti Nad Labem, CZ)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Milos Taborsky

Masaryk Hospital, Usti Nad Labem (Czechia)

11 presentations

2 followers

2 more presentations in this session

Prediction of risk for sudden cardiac death beyond the ejection fraction

Speaker: Professor V. Kutyifa (Rochester, US)

Do we need new randomised trials to assess the role of the defibrillator? - the PROFID EHRA trial

Speaker: Doctor N. Dagres (Berlin, DE)

Access the full session

The role of the primary prevention defibrillator after myocardial infarction in the era of modern heart failure therapy: the PROFID project

Speakers: Professor M. Taborsky, Professor V. Kutyifa, Doctor N. Dagres

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources